GESTIÓN EN SALUD PÚBLICA: Market Highlight:The Outsourcing of Pharmaceuticals :: AZoNetwork

martes, 20 de febrero de 2018

Market Highlight:The Outsourcing of Pharmaceuticals :: AZoNetwork - Marketing Science

	February 20, 2018
	Biochemistry
	The latest biochemistry news from AZoNetwork

Market Highlight: The Outsourcing of Pharmaceuticals

Pharmaceutical development costs can reach into the billions, and it takes a long time to bring a new drug to market. Even then, many drugs fail to be clinically effective and subsequently never see the light of day.

Therefore, pharmaceutical companies are not always eager to utilize their onsite resources for drug R&D and choose to outsource.

Read Full Article Here

			Researchers solve crystal structure for enzyme that plays key role in DNA methylation A research team led by a biochemist at the University of California, Riverside has solved the crystal structure for an enzyme that plays a key role in DNA methylation, the process by which methyl groups are added to the DNA molecule.

			Detailed phenotypic information on resistance genes can guide future drug development The genes that are able to equip bacteria with resistance to clinically used antibiotics have been found in many different natural environments. Nevertheless, a functional overview of the resistance genes found in common human bacterial pathogens has been missing so far.

	Researchers identify cause of severe genetic disease Mutations in the p63 protein lead to a number of disorders, but none is as severe as the AEC syndrome. Scientists at Goethe University Frankfurt in collaboration with a research group from the University of Naples Federico II have now discovered that this syndrome resembles diseases such as Alzheimer's, Parkinson's or ALS more closely than it does other p63-based syndromes.

	Researchers shine light on ‘molecular butcher’ using neutron beams Tucked away inside cell membranes, a molecular butcher does the bidding of healthy cells but also of disease agents. It has been operating out of clear view, but researchers just shined a mighty spotlight on it.

	Biomedical, Biophysical and Biological Applications of AFM Dr. Thomas Mueller is the Director of Product Management in the AFM business unit of Bruker’s Nano Surfaces Division. Thomas has been with Bruker for 12 years having held positions in applications and product management, and is the author of over 50 publications, reviews, and application notes.

	Prediction of the Biochemical Methane Potential for More Efficient Biogas Production When manufacturing biogas, manufacturers aim for the maximum possible methane content, as methane is the combustible fraction of biogas.